top of page
Eye Test

ADVANCED DIAGNOSTIC EQUIPMENT 

The following are just some examples of the diagnostic instruments and equipment used at
Barnard Levit Optometrists.

Optomap

Optometrists at Barnard Levit have been using Optos technology since 2001 to examine the retina (the light-sensitive layer at the back of the eye), forming an integral part of the routine Eye Examination for all patients, from babies to the elderly.

 

  • Whereas conventional retinal photography takes a picture of approximately just 10% of the retina, the Optomap captures up to 85% of the retina and the anatomical layer below it, the choroid, usually without the need for dilation of the pupils. 

  • Optomap technology provides an added advantage of enabling hyperfluorescent images to be taken as part of the screening process for subtle retinal disease. 

  • Professor Barnard has presented numerous lectures on the Optos technology as well as publications.

Optomap
Optomap
Slit lamp
Slit Lamp The Haag-Streit BQ 900 

Slit Lamp

The Haag-Streit BQ 900 

The Haag-Streit BQ 900 video lit lamp enables photographs and videos to be captured of conditions of the eye lids, cornea, conjuctiva, anterior chamber, iris and lens. The Haag-Streit BQ 900 video lit lamp enables photographs and videos to be captured of conditions of the eye lids, cornea, conjuctiva, anterior chamber, iris and lens.  

Eye Pressure Instruments

Eye Pressure Instruments

Goldmann Applanation Tonometer

The Goldmann Applanation Tonometer is used for diagnosis and monitoring of patients with Ocular Hypertension or Glaucoma. This instrument is considered to be the ‘gold standard’ and its use forms part of the NICE Guidelines for Glaucoma.  

Goldmann Applanation Tonometer

Keeler Pulsair

The Keeler Pulsair, as well as the iCare Tonometer, are used as a routine screener for patients 18 years old and above.  

Keeler Pulsair

Pascal DCT

The Pascal DCT is also used by our Optometrists. This mechanism is arguably more accurate than the Goldmann, as it compensates for corneal thickness, whilst also providing a measurement of the pulse pressure associated with the systolic-diastolic cardiac cycle, which causes the eye pressure to fluctuate with the heartbeat. 

Pascal DCT
OCT
OCT

OCT

  • The OCT enables us to carry out a non-invasive “biopsy” of the retina, macula and optic nerve and obtain a 3-D analysis.

  • Introduced to Barnard Levit in 2005, as the first in the UK to incorporate the OCT into primary care practice.  

  • This instrument provides a non-invasive, non-contact, micron resolution analysis of eye tissues, enabling real-time imaging of tissue structure or pathology with a resolution of 5 microns.

The OCT is used to assess a wide range of eye conditions, including: 


Early Glaucoma Detection and Monitoring

It is estimated that 50% of patients with glaucoma in the UK are undiagnosed and up to about half of all patients with glaucoma have “normal” eye pressures.   OCT enables us to study in detail the structure of the optic nerve and assist detection of the most subtle changes due to glaucoma.  

 

Whilst it does not replace conventional optic nerve examination, including Visual Field testing and the measurement of eye pressure, it helps us detect glaucoma as early as possible. OCT is suggested for patients with a risk of developing glaucoma, such as those with a family member with the condition, or patients with other signs detected by your optometrist. 

 

Macular Degeneration and Macular Holes

 Age related macular degeneration (AMD) is the commonest cause of poor vision and blindness in the UK.

 

Early detection is a challenge because most of us show age related changes as we get older. These early, “dry” macular changes are insidious and increase the risk of the patient developing the more serious type of AMD, (wet AMD). The latter occurs due to fine blood vessels growing deep in macula of the retina. These vessels are fragile and can leak, hence the name “wet”.  OCT assessment of the macular will assist us in monitoring the “dry” changes and detecting new vessel growth at an earlier stage. It also allows us to differentially diagnose macular holes and pseudo-holes. 

 

Diabetes

Diabetic patients are prone to leaks of blood and plasma within the retina.  One of the more difficult diabetic changes to detect is oedema (or swelling) of the macula because its appearance is very subtle.

 

 OCT enables us to measure very accurately the thickness of the macula to help detect early changes.  OCT compliments the Optos Daytona wide field imaging system and conventional indirect ophthalmoscopy, which we use routinely on all patients to view their retina. 

Pentacam
Pentacam

Pentacam

  • The Pentacam system uses a rotating Scheimpflug camera capable of creating a three-dimensional map of the cornea.
     

  • The Pentacam is used for the design of certain types of complex contact lenses, as well as the evaluation and detection of Ectatic Diseases, Keratoconus and cataracts.
     

  • This exceptional system enables advanced calculations for the power of intraocular lenses, guiding deep anterior lamellar keratoplasty, and imaging of post-LASIK or photorefractive keratectomy (PRK) eyes.
     

  • Ideally, corneal tomography is able to characterise the level of susceptibility each patient has for the development of ectasia.
     

  • The detection of early ectasia provides patients the option to start treatment such as collagen-cross linking that may slow or halt progression of the disease.

Macular Pigment Density screener

MPS II Macular Pigment Density Screener

The Elektron Technology MPS II measures the density of pigment at the macula.  

  • Macular pigment affords protection against harmful blue and ultra-violet light, which can damage the retina, while also being a source of glare. 

  • Reduced macular pigment density has been shown to be a risk factor for age related Macular Degeneration.

  • Detection of low levels of pigment at the maculae will enable your optometrist or ophthalmologist to provide you with nutritional advice, which may include supplements of Lutein, Zeaxanthin and Meso-Zeaxanthin.   

  • Follow up tests will reveal whether the protective pigment levels increase over time with your dietary changes.

  • Evidence based clinical publications relating to macular piment and AMD can be reviewed at Elektron.

MPS II Macular Pigment Density Screener
Diopsys ERG & VEP
Diopsys.jpg

ERG & VEP

The Electroretinogram (ERG) measures function of the retina for ocular sequelae, results of other diseases, injury, therapy or trauma.

 

The Visual Evoked Potential (VEP) test measures the integrity of the complete visual pathway to the visual cortex for subclinical abnormalities caused by systemic diseases and disorders. 

 

The purpose of these tests is to differentiate ocular from systemic disorders and other conditions that affect vision.

 

The Diopsys® NOVA™ ERG and VEP Vision Testing System provides visual electrophysiology, components of the electroencephalogram that are specific and objective measures of visual pathway function (strength and speed). 

In 2016 the practice was the first optometry practice to install the Diopsys ERG & VEP testing suite.

Patients Who Would Benefit Most: 

  1. Have special needs, difficulty taking standard vision tests (e.g. pediatric, non-verbal).
     

  2. May require more specific testing due to the nature of subclinical effects on the visual pathway.  

 

  • Vascular Diseases-systemic hypertension, diabetes mellitus, vasculitis, hematologic diseases, cerebrovascular disease, increased intracranial pressure. 

  • Endocrine- thyroid eye disease, metabolic storage diseases.

  • Neurological-Multiple Sclerosis, Pupillary function, optic nerve disorders (e.g., optic nerve glioma), chiasmal tumors, myasthenia gravis, central nervous system defects or aneurysm, drug or heavy metal toxicity.

  • Toxicity-hydroxychloroquine, tamoxifen, or phenothiazines,tamoxifen, or phenothiazines,  Nutritional ON, Toxic ON, drug or heavy metal toxicity.

  • Infectious- acquired immunodeficiency syndrome, tuberculosis, syphilis, histoplasmosis, toxoplasmosis.

  • Neoplastic- primary or metastatic tumours, orbital tumour

  • Trauma- Cerebral Oedema, compression of brain Cerebral disorder, TBI, Optic Nerve/Pathway disorder.

  • Autoimmune- sarcoidosis, immune-mediated diseases.

 

We are pleased to receive referrals from other optometrists or medical practitioners to carry out these tests.  Our new visual electrophysiology diagnostic testing benefits us both for appropriate referral, co-management and treatments. 

Colorimeter

Colour and Contrast Vision Testing

Colour and contrast testing
colorimeter.png

Intuitive Colorimetry

  • This diagnostic test is used to determine the optimum tint to help alleviate or reduce symptoms of perceptual distortions, associated with Visual Stress Syndrome.  

 

  • This condition is reported by some patients who have dyslexia, migraines or photosensitive epilepsy.

  • The instrument independently changes the 3 parameters of colour, hue, saturation and brightness, while the eyes are colour adapted. 
     

  • This technology is supported by peer reviewed research studies and controlled trials. However, it is deemed controversial by some clinicians and scientists. For this reason, the practice will usually follow a step-by-step diagnostic process when assessing children, to try and rule out any placebo effect.
     

  • Barnard Levit Optometrists was one of the first practices in the world to use the Intuitive Colorimeter, from August 1993.

CSV-1000-1.png

Contrast Sensitivity

Contrast Sensitivity technology assesses the quality of vision. 

 

  • Contrast Sensitivity measures visual sensitivity at various contrast levels and can therefore detect and quantify visual performance problems better, and at a much earlier stage than the standard visual acuity testing.  

  • Contrast sensitivity is particularly useful in documentation of visual performance in the presence of: 

    • Cataract

    • Early detection of Glaucoma  

    • Macular pathologies 

       

  • Used to monitor treatment efficacy in glaucoma, cataracts, macular degeneration, and diabetic eye disease.  

  • Useful tool in understanding visual difficulties after all types of refractive surgery and contact lens vision correction.  

Background 
  •  Research shows that the standard visual acuity assessment only tests one’s ability to see black on white high contrast letters.  

  • Many ocular and visual problems remain undetected when only high contrast vision is tested.  

  • Standard acuity measurement was originally designed as a tool to quantify optical blur and prescribe spectacles, it does not represent an accurate and representative measure of visual function in the real world.

  • At Barnard Levit we utilise the CSV1000E, manufactured by VectorVision USA.  

     

    This is a research grade standardised and fully validated Contrast Sensitivity testing equipment.   

cct_edited_edited.jpg

Cone Contrast Test

  • The Rabin Cone Contrast Test (CCT) is a revolutionary new color vision test sensitive enough to detect both hereditary and acquired deficiency.

  •  Barnard Levit Optometrists were the first clinic in the UK to introduce the Rabin Cone Contrast Test to enable precise evaluation of their patients' colour vision. 

  • Research shows Cone Function loss is affected early, as a result of numerous diseases, including:  

     

This test is approved as the sole colour vision test by the US Air Force. 

 

The CCT has sensitivity and specificity comparable to anomalascope testing and exceeds Pseudo Isochromatic Plate testing in experienced observers. The CCT provides a rapid, clinically expedient measure of colour vision for quantifying normal colour performance, diagnosing and quantifyng severity of heriditary colour vision deficiency, and detection of aquired colour vision sensitivity loss, due to ocular, neurological and/or systemic disease, as will as injury or physiological stressors such as altitude and fatigue. (Invest Ophthalmol Vis Science, 2011, 52; 816-820). 

 

Barnard Levit Optometrists use this test to: 

  • Diagnose the type and severity of heriditary colour vision defects to enable advice to be provided regarding career choice and to enable parents to inform the school of the colour vision anomaly 

  • Assist in the diagnosis of a wide range of eye, neurological and systemic conditions.

  • Provide accurate information to patients wishing to obtain a commercial or private pilot's licence. 

Tearlab Osmolarity system

TearLab® Osmolarity System

  • The TearLab® Osmolarity System is intended to measure the osmolarity of human tears to aid in the diagnosis of ocular surface health disease in patients, such as Dry Eye Disease.

 

  • Ocular Surface Disease (OSD) may affect the clarity and stability of vision and reduce the accuracy of refractive diagnostic tests. OSD can also negatively impact the results of surgical procedures, including cataract surgery, leading to refractive surprises and dissatisfaction.

 

  • The Osmolarity System is an objective, precise and quantitative diagnostic test, done in conjunction with other methods of clinical evaluation, including the use of Inflammadry and Lipiview equipment. These tests guide Optometrists in gaining immediate insights into Ocular Surface Disease.

Osmolarity machine
Osmolarity 2 (002)_edited.jpg

How TearLab Works:

  • The test requires a tear sample of 50 nl – collected at the tear film and transported via microfluidics onto the testcard chip. The Osmolarity level (salt content) of the tear is calculated through electrical impedance technology. An osmolarity value is then given in mOsm/L and will fall in a range between 290-400 mOsm/L. The result must then be interpreted by the Optometrist, to give a diagnosis based on Dry Eye Disease severity.

 

  • TearLab® also supplements your treatment plan, to ultimately achieve a low and stable tear osmolarity which ensures a stable tear film and healthy ocular surface.

TearScience™ LipiView™

TearScience™ LipiView™ Ocular Surface Interferometer

  • The TearScience LipiView system is a sophisticated device to enable the diagnosis and assessment of the factors that contribute to Dry Eye Disease.

  • Lipiview technology measures lipid layer thickness and quality, captures blink dynamics, including detection of partial blinks, as well as Meibomian Gland function and integrity.

  • Dry Eye conditions, including Meibomian Gland Dysfunction (MGD), not only cause discomfort, but significantly degrade the quality of vision (Mijianovic et al 2007). MGD and other Dry Eye conditions do not resolve on their own, but are chronic and progressive (Rao, 2010). 

  • The TearScience system produces high-resolution videography that depict how well ocular lipids disperse, through variations in light patterns reflected off the tear film, referred to as an interferogram.

  • Patients with MGD can be treated with a range of therapies, including hot compresses, eye-drops and specific oral antibiotics.

  • However, Some patients do not obtain relief from these methods, to whom we might suggest LipiFlow treatment.

Lipiview technology
compress eyemask

Contact Us


You can reach Barnard Levit Optometrists by phone: 020 8458 0599 or post: Zamenhof House, 58 Clifton Gardens, London, NW11 7EL, or email: reception@barnardlevit.com

bottom of page